Diagnostics: GenMark Diagnostics, Inc. (GNMK)

• Publication date: April 2012
• Report size: 188 pages

This report is a source for data, analysis and actionable intelligence on the GenMark Diagnostics, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product description,...

This report is a source for data, analysis and actionable intelligence on the GenMark Diagnostics, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Diagnostics Industry

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
GenMarch k Diagnostics, Inc. - Major Products and Services 5
GenMarch k Diagnostics, Inc. Pipeline Products by Equipment Type 6
GenMarch k Diagnostics, Inc. Pipeline Products by Development Stage 7
GenMarch k Diagnostics, Inc. Pipeline Products by Therapy Area 8
2D6 Tamoxifen Metabolism Test 9
Product Status 9
Product Description 9
Product Patent Details 9
eSensor 2C19 Test 29
Product Status 29
Product Description 29
Product Patent Details 29
eSensor KRAS/BRAF Test 51
Product Status 51
Product Description 51
Product Patent Details 52
eSensor Respiratory Viral Panel 73
Product Status 74
Product Description 74
Product Patent Details 74
GenMarch k Diagnostics, Inc. - Top Competitors 97
GenMarch k Diagnostics, Inc. - Key Executives 98
GenMarch k Diagnostics, Inc. - Operations and Subsidiaries 99
Head Office 99
Recent Developments 100
March 17, 2011: GenMarch k Appoints Paul Ross As CFO 100
March 17, 2011: GenMarch k Receives Medical Device Manufacturing License For Carlsbad Facility 100
March 03, 2011: GenMarch k Diagnostics Reports Total Sales s Of US$ 2.5m In 2010 100
March 01, 2011: GenMarch k Dismisses Patent Lawsuit Against Caliper 100
February 24, 2011: Life Technologies And Applied Biosystems Dismisses Patent Infringement Lawsuit Against GenMarch k 100
November 04, 2010: GenMarch k Diagnostics Reports Q3 2010 Results 100
September 01, 2010: GenMarch k Diagnostics Appoints James Fox To Board 101
August 09, 2010: GenMarch k Diagnostics Reports Q2 2010 Results 101
July 22, 2010: GenMarch k Diagnostics To December lare Q2 2010 Results 101
Appendix 102
Methodology 102
About GlobalData 102
Contact Us 102
Disclaimer 102


List of Tables

GenMarch k Diagnostics, Inc., Major development 1
GenMarch k Diagnostics, Inc. Key Pipeline Products by Equipment Type 1
GenMarch k Diagnostics, Inc. Key Pipeline Products by Therapy Area 1
GenMarch k Diagnostics, Inc. Key Pipeline Products by Development Stage 1
GenMarch k Diagnostics, Inc. Key Pipeline Products by Trial Phase 1
GenMarch k Diagnostics, Inc., Major development 4
GenMarch k Diagnostics, Inc., Major Products and Services 5
GenMarch k Diagnostics, Inc. Number of Pipeline Products by Equipment Type 6
GenMarch k Diagnostics, Inc. Pipeline Products by Equipment Type 6
GenMarch k Diagnostics, Inc. Number of Pipeline Products by Development Stage 7
GenMarch k Diagnostics, Inc. Pipeline Products by Development Stage 7
GenMarch k Diagnostics, Inc. Number of Pipeline Products by Therapy Area 8
GenMarch k Diagnostics, Inc. Pipeline Products by Therapy Area 8
2D6 Tamoxifen Metabolism Test - Product Status 9
2D6 Tamoxifen Metabolism Test - Product Description 9
2D6 Tamoxifen Metabolism Test - Patent Details 9
eSensor 2C19 Test - Product Status 29
eSensor 2C19 Test - Product Description 29
eSensor 2C19 Test - Patent Details 29
eSensor KRAS/BRAF Test - Product Status 51
eSensor KRAS/BRAF Test - Product Description 51
eSensor KRAS/BRAF Test - Patent Details 52
eSensor Respiratory Viral Panel - Product Status 74
eSensor Respiratory Viral Panel - Product Description 74
eSensor Respiratory Viral Panel - Patent Details 74
GenMarch k Diagnostics, Inc., Key Executives 98


List of Figures

GenMarch k Diagnostics, Inc. Key Pipeline Products by Equipment Type 1
GenMarch k Diagnostics, Inc. Pipeline Products by Equipment Type 6
GenMarch k Diagnostics, Inc. Pipeline Products by Development Stage 7
GenMarch k Diagnostics, Inc. Pipeline Products by Therapy Area 8

Companies mentioned Assurance Biosciences, Inc.
Diagnostic BioSystems
Exagen Diagnostics, Inc.
Saladax Biomedical, Inc.
Epinex Diagnostics Incorporated